Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 226 Breast Neoplasms 223 Prostatic Neoplasms 163 Multiple Myeloma 147 Neoplasms 130 Leukemia, Myeloid, Acute 117 Colorectal Neoplasms 117 Lung Neoplasms 112 Neoplasm Metastasis 95 Squamous Cell Carcinoma of Head and Neck 90 Carcinoma, Hepatocellular 88 Melanoma 83 Lymphoma 81 Triple Negative Breast Neoplasms 74 Pancreatic Neoplasms 73 Ovarian Neoplasms 72 Sarcoma 66 Lymphoma, Large B-Cell, Diffuse 63 Carcinoma, Renal Cell 63 Brain Neoplasms 62 Recurrence 58 Head and Neck Neoplasms 57 Stomach Neoplasms 54 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Leukemia, Lymphocytic, Chronic, B-Cell 53 Urinary Bladder Neoplasms 52 Hematologic Neoplasms 52 Lymphoma, Non-Hodgkin 51 Small Cell Lung Carcinoma 50 Endometrial Neoplasms 47

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Locoregional Recurrence × 90 days × Clear all

NCT05467891 2026-04-08

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡